Systemic therapy for brain metastases.

Area of Science:

• Neuro-oncology
• Translational Cancer Medicine
• Clinical Neurology

Background:

• Metastases originating outside the central nervous system (CNS) are the most frequent brain tumors, often linked to poor patient outcomes.
• Despite advances in systemic cancer treatment, CNS metastases are increasingly common, necessitating specialized therapeutic approaches.
• Treating brain metastases requires careful consideration of primary tumor biology and the unique neurological microenvironment, complicated by therapies effective outside the blood-brain barrier (BBB) potentially failing within it.

Purpose of the Study:

• To provide an updated review of recent therapeutic advancements for the three most common types of brain metastases.
• To highlight novel treatment strategies addressing the challenges of CNS metastases from lung cancer, breast cancer, and melanoma.

Main Methods:

• Comprehensive literature review of recent advancements in the treatment of brain metastases.
• Focus on novel therapeutic avenues for lung cancer, breast cancer, and melanoma brain metastases.
• Analysis of treatment efficacy considering the blood-brain barrier and neurological environment.

Main Results:

• Recent research has yielded intriguing and novel therapeutic strategies for managing brain metastases.
• Specific advancements are detailed for lung cancer, breast cancer, and melanoma, addressing their unique biological and clinical characteristics.
• Emerging therapies show promise in overcoming the challenges posed by the blood-brain barrier in CNS cancer treatment.

Conclusions:

• Effective management of brain metastases requires a nuanced understanding of primary tumor biology and the CNS environment.
• Novel therapeutic approaches are expanding treatment options for patients with lung, breast, and melanoma brain metastases.
• Continued research into therapies that penetrate the blood-brain barrier is crucial for improving outcomes in CNS oncology.